INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT07667686 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-29
Clinical trial NCT07667686 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-06-29
Clinical trial NCT06892548: collaborators removed: Biotheus Inc..
Clinical trial NCT07655505: status: ENROLLING_BY_INVITATION → RECRUITING.
Clinical trial NCT03448042 updates: 1. completion date: 2027-11-30 → 2027-04-30 2. primary completion date: 2027-11-30 → 2027-04-30
Clinical trial NCT06283966: enrollment: 5250 → 5000 participants.
Clinical trial NCT06436924 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2026-03-19 3. primary completion date: 2025-12-30 → 2026-03-19 4. enrollment: 678 → 569 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07114822 updates: 1. status: RECRUITING → NOT_YET_RECRUITING 2. start date: 2025-10-21 → 2026-10-01 3. completion date: 2026-05-01 → 2027-02-01 4. primary completion date: 2025-12-01 → 2027-02-01 5. collaborators added: National Center for Complementary and Integrative Health (NCCIH)
Clinical trial NCT07187297: primary completion date: 2026-09-01 → 2027-02-01.
Clinical trial NCT06951880 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-10-25 → 2027-12-20 3. primary completion date: 2027-10-25 → 2027-12-20
Clinical trial NCT06494020: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06659341 updates: 1. completion date: 2027-07-30 → 2027-09-06 2. primary completion date: 2027-01-11 → 2027-04-26
Clinical trial NCT07454889: start date: 2026-07-31 → 2026-09-15.
Clinical trial NCT07642284: start date: 2026-05-30 → 2026-09-08.
Clinical trial NCT06649539 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. collaborators added: Endo USA Inc., a Keenova Therapeutics Company 3. collaborators removed: Endo Pharmaceuticals
Clinical trial NCT05236036 updates: 1. primary completion date: 2026-01-12 → 2029-01-03 2. enrollment: 60 → 86 participants 3. enrollment type: ESTIMATED → ACTUAL